Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07185165
What this trial is testing

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

Who this might be right for
Prostate Carcinoma
Jonsson Comprehensive Cancer Center 81
Testing effectiveness (Phase 2)Looking for participantsNCT07255404
What this trial is testing

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
BioNTech SE 105
Testing effectiveness (Phase 2)Study completedNCT01592370
What this trial is testing

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

Who this might be right for
Non-Hodgkin's LymphomaHodgkin LymphomaMultiple Myeloma
Bristol-Myers Squibb 320
Not applicableStudy completedNCT03927183
What this trial is testing

Extended Support for Persons With Pituitary Tumours After Surgery

Who this might be right for
Pituitary Tumor BenignSurgery
Göteborg University 86
Large-scale testing (Phase 3)Study completedNCT01106040
What this trial is testing

Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes

Who this might be right for
Breast CancerMelanoma
Navidea Biopharmaceuticals 163
Testing effectiveness (Phase 2)Ended earlyNCT00452140
What this trial is testing

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

Who this might be right for
Metastatic Breast CancerAdvanced Breast Cancer
Neovii Biotech 40
Not applicableStudy completedNCT05793710
What this trial is testing

Effects o Laughing Qigong Program on Psychological Outcomes and the Physiological Immunological Responses

Who this might be right for
Breast Cancer Survivors
National Taipei University of Nursing and Health Sciences 71
Not applicableUnknownNCT05991947
What this trial is testing

Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer

Who this might be right for
Gastric CancerHealthy
Zhejiang Cancer Hospital 1,100
Testing effectiveness (Phase 2)Looking for participantsNCT06469944
What this trial is testing

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Who this might be right for
Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Looking for participantsNCT06731907
What this trial is testing

Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 90
Testing effectiveness (Phase 2)Study completedNCT02832167
What this trial is testing

An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread

Who this might be right for
Cancer
Bristol-Myers Squibb 239
Early research (Phase 1)Study completedNCT04165967
What this trial is testing

Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

Who this might be right for
Advanced Melanoma
University Hospital, Basel, Switzerland 9
Not applicableEnrolling By InvitationNCT07347158
What this trial is testing

Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.

Who this might be right for
Colon CancerInflamatory Bowel Disease (Crohn's and Ulcerative Colitis)Colitis Ulcerative
Hospital Clinico Universitario de Santiago 70
Early research (Phase 1)WithdrawnNCT02193672
What this trial is testing

A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02320058
What this trial is testing

An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself

Who this might be right for
Melanoma
Bristol-Myers Squibb 119
Post-approval studies (Phase 4)Ended earlyNCT04134208
What this trial is testing

An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT03459222
What this trial is testing

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 229
Large-scale testing (Phase 3)Ended earlyNCT04876651
What this trial is testing

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Ltd 16
Early research (Phase 1)Study completedNCT02792465
What this trial is testing

Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid CancersBreast Cancer
University Health Network, Toronto 52
Testing effectiveness (Phase 2)Looking for participantsNCT06827236
What this trial is testing

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast CancerUnresectable Breast CarcinomaMetastatic Breast Cancer
BioNTech SE 380
Next Page